Lung Cancer Screening Eligibility Assessment

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
Abramson Cancer Center at Penn Medicine
Study ID
NCT06133816
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Framed Introductory Message A — BEHAVIORAL
    Randomly assign patients to receive introductory message encouraging them to complete the survey (version A).
  • Framed Introductory Message B — BEHAVIORAL
    Randomly assign patients to receive introductory message encouraging them to complete the survey (version B).
  • Framed Introductory Message C — BEHAVIORAL
    Randomly assign patients to receive introductory message encouraging them to complete the survey (version C).
  • Framed Tobacco Use Message A — BEHAVIORAL
    Randomly assign patients to receive norming message related to tobacco use (version A).
  • Framed Tobacco Use Message B — BEHAVIORAL
    Randomly assign patients to receive norming message related to tobacco use (version B).
  • Financial Incentive — BEHAVIORAL
    Randomly assigned patients to be entered into a drawing to receive a $100 gift card.

Study Details

The primary purpose of this study evaluate if different messaging impacts response rates to a brief survey (i.e., the simplified eligibility tool) that is designed to estimate pack-year eligibility for lung cancer screening (LCS). This will help inform the best way to increase response rates to the tool in future intervention studies designed to increase LCS, and expand upon survey methodology in general.

Key Dates

Start date
Jul 31, 2023
Status verified
May 2025
Primary completion
Jan 31, 2024
Completion
Jan 31, 2024

Study Design

Enrollment
6,125 participants (actual)
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Arm 1 (Introductory Message A + Tobacco Use Message A + Incentive)
    Participants will receive two framed messages (AA) plus an incentive
  • Experimental: Arm 2 (Introductory Message A + Tobacco Use Message A)
    Participants will receive two framed messages (AA)
  • Experimental: Arm 3 (Introductory Message A + Tobacco Use Message B + Incentive)
    Participants will receive two framed messages (AB) plus an incentive
  • Experimental: Arm 4 (Introductory Message A + Tobacco Use Message B)
    Participants will receive two framed messages (AB)
  • Experimental: Arm 5 (Introductory Message B + Tobacco Use Message A + Incentive)
    Participants will receive two framed messages (BA) plus an incentive
  • Experimental: Arm 6 (Introductory Message B + Tobacco Use Message A)
    Participants will receive two framed messages (BA)
  • Experimental: Arm 7 (Introductory Message B + Tobacco Use Message B + Incentive)
    Participants will receive two framed messages (BB) plus an incentive
  • Experimental: Arm 8 (Introductory Message B + Tobacco Use Message B)
    Participants will receive two framed messages (BB)
  • Experimental: Arm 9 (Introductory Message C + Tobacco Use Message A + Incentive)
    Participants will receive two framed messages (CA) plus an incentive
  • Experimental: Arm 10 (Introductory Message C + Tobacco Use Message A)
    Participants will receive two framed message (CA)
  • Experimental: Arm 11 (Introductory Message C + Tobacco Use Message B + Incentive)
    Participants will receive two framed messages (CB) plus an incentive
  • Experimental: Arm 12 (Introductory Message C + Tobacco Use Message B)
    Participants will receive two framed messages (CB)

Primary Outcome Measure

Full Survey Completion [ Time Frame: 7 days ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of PennsylvaniaPhiladelphiaPennsylvania19104-

Find similar trials in Philadelphia, PA

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
University of Pennsylvania· Philadelphia, PA

Related Studies